The data strongly suggest that this molecular mechanism offers a new treatment target for diseases thought to be caused by ER stress such as neurodegenerative diseases19, 20 and for diseases associated with reduced Sig-1R levels such as schizophrenia and depression.5, 6. This evidence concerns the gene SIGMAR1 and major depressive disorder.